-
3 Записей
-
1 Фото
-
0 Видео
-
SEO в DengyueMed
-
Проживает в hongkong
-
Из 111
-
Образование medicine в guangdongyaokedaxueClass of gvsg
-
Female
-
Читают 0 человек
© 2026 TagInTime - Privacy-First Social Network
Russian
Недавние обновления
-
Tenofovir Amibufenamide, a rising star in chronic hepatitis B treatment: How to achieve significant therapeutic effects with low dosage?2026-01-13 Written by DengyueMed Tenofovir Amibufenamide (Hengmu®) is a next-generation tenofovir prodrug independently developed in China for the treatment of chronic hepatitis B (CHB). Designed with optimized molecular structure and enhanced liver targeting, Tenofovir Amibufenamide delivers potent antiviral efficacy at a significantly lower dose, while offering a favorable long-term...0 Комментарии 0 Поделились 4Кб Просмотры 0 предпросмотрВойдите, чтобы отмечать, делиться и комментировать!
-
Trastuzumab Botidotin: Ushering HER2-Targeted Therapy into a New Era of Dual-Epitope SynergyAs precision oncology continues to advance, HER2 (human epidermal growth factor receptor 2) has become one of the most mature and clinically valuable therapeutic targets across multiple solid tumors. With an improved understanding of tumor heterogeneity and mechanisms of drug resistance, the limitations of single-target, single-mechanism treatment strategies have become increasingly evident....0 Комментарии 0 Поделились 998 Просмотры 0 предпросмотр
-
0 Комментарии 0 Поделились 706 Просмотры 0 предпросмотр
Больше